Written by students who passed Immediately available after payment Read online or as PDF Wrong document? Swap it for free 4.6 TrustPilot
logo-home
Document preview thumbnail
Preview 4 out of 73 pages
Exam (elaborations)

LPN HESI Pharmacology 2026 Practice Exam: 200 Verified Questions with Rationales & A+ Guide

Document preview thumbnail
Preview 4 out of 73 pages

Prepare for the LPN HESI Pharmacology 2026 exam with this comprehensive practice test. Features 200 exam-style questions with verified answers and detailed clinical rationales. Updated for the latest exam content. A+ guaranteed!

Content preview

LPN HESI PHARMACOLOGY 2026
COMPLETE PRACTICE EXAM -
QUESTIONS VERIFIED ANSWERS
LATEST MOCK PRACTICE SET
200 Questions with Answers and Detailed Rationales


100 PERCENT GUARANTEED PASS


INSTANT DOWNLOAD ANSWERS INCLUDED



IMPORTANCE OF THIS DOCUMENT
This comprehensive examination preparation guide has been meticulously developed to help you succeed in the
LPN HESI PHARMACOLOGY 2026 COMPLETE PRACTICE EXAM - QUESTIONS VERIFIED ANSWERS WITH
DETAILED CLINICAL RATIONALES REAL EXAM QUESTIONS | A+ GRADED UPDATED 2026 EDITION. It
contains 200 carefully selected questions that reflect the most current exam content and testing strategies. Each
question is accompanied by a correct answer and a detailed rationale that explains the underlying
pathophysiology, pharmacology, or clinical reasoning.

Self-Assessment – Test your knowledge and Exam Preparation – Familiarize yourself with the
identify areas requiring further question format and content
study areas

Concept Reinforcement – Deepen your Confidence Building – Develop test-taking
understanding through strategies and reduce
evidence-based exam anxiety
rationales
Time Management – Practice answering
questions under simulated
exam conditions




Review Summary 200 Questions


Foundations - Application - LPN HESI Pharmacology 2026 Complete WITH Detailed Clinical Rationales
REAL A Updated 2026 Edition Pharmacology FOR Licensed Practical Nurses LPN HESI Comprehensive
Review Undergraduate YEAR 2 LPN Bridge Program WITH Graduate-level Pharmacology Rigor
All answers with rationales

,Table of Contents

Section A - Pharmacokinetics AND Section B - Autonomic Nervous
Pharmacodynamics System Drugs
Questions 1 to 50 Questions 51 to 100



Section C - Cardiovascular AND Renal Section D - Central Nervous System
Drugs Drugs
Questions 101 to 150 Questions 151 to 200

,Section A - Pharmacokinetics AND Pharmacodynamics

Q1.
A patient on warfarin requires emergency surgery. Prothrombin time is 28 seconds (INR
2.8). Which agent should be administered to reverse anticoagulation rapidly?


A. Vitamin K (phytonadione) 10 mg IV B. Protamine sulfate 50 mg IV

C. Fresh frozen plasma (FFP) 2 units IV D. Prothrombin complex concentrate (PCC)
4-factor 25 units/kg IV
Correct: D - Prothrombin complex concentrate (PCC) 4-factor 25 units/kg IV


Rationale:For emergency reversal of warfarin with elevated INR, 4-factor PCC is preferred
due to rapid onset and complete reversal. Vitamin K takes 6-24 hours. Protamine reverses
heparin, not warfarin. FFP requires cross-matching and carries infection risk, while PCC is
faster and more effective.

Q2.
A patient receiving IV gentamicin develops tinnitus and nystagmus. Serum gentamicin
trough level is 4.2 mcg/mL (therapeutic trough: <2 mcg/mL). Which pathophysiologic
mechanism best explains these findings?


A. Displacement of histamine from mast B. Inhibition of protein synthesis in cochlear
cells in the inner ear hair cells leading to mitochondrial
dysfunction

C. Competitive blockade of GABA receptors D. Direct vasoconstriction of the labyrinthine
in the vestibular nuclei artery causing ischemia
Correct: B - Inhibition of protein synthesis in cochlear hair cells leading to mitochondrial
dysfunction


Rationale:Aminoglycosides like gentamicin accumulate in inner ear hair cells, bind to
ribosomal RNA, and inhibit protein synthesis, causing mitochondrial damage and apoptosis.
This leads to ototoxicity (tinnitus, nystagmus) at high trough levels. Options A, C, and D are
not mechanisms of aminoglycoside ototoxicity.

Q3.
Which of the following best explains why a patient with chronic kidney disease (GFR 25
mL/min) requires a reduced dose of vancomycin?


A. Decreased plasma protein binding B. Reduced renal clearance prolongs
increases free vancomycin concentration vancomycin half-life, increasing risk of
nephrotoxicity




Page 3

, Section A - Pharmacokinetics AND Pharmacodynamics



C. Impaired hepatic metabolism leads to D. Increased volume of distribution lowers
accumulation of toxic metabolites peak serum concentrations

Correct: B - Reduced renal clearance prolongs vancomycin half-life, increasing risk of
nephrotoxicity


Rationale:Vancomycin is primarily eliminated unchanged by glomerular filtration. In CKD,
reduced clearance prolongs half-life, so dosing interval must be extended or dose reduced to
avoid accumulation and nephrotoxicity. Option A is incorrect because vancomycin is not
highly protein bound. Option C is false; hepatic metabolism is minimal. Option D is not the
primary reason for dose adjustment.

Q4.
A patient on lithium carbonate for bipolar disorder develops polyuria, polydipsia, and a
serum lithium level of 1.8 mEq/L (therapeutic: 0.6-1.2). Which intervention is most
appropriate?


A. Administer sodium polystyrene sulfonate B. Discontinue lithium and administer IV
to enhance lithium elimination normal saline at 150 mL/hour

C. Increase lithium dose to achieve D. Start furosemide 40 mg IV to promote
therapeutic level of 1.0 mEq/L lithium excretion
Correct: B - Discontinue lithium and administer IV normal saline at 150 mL/hour


Rationale:Lithium toxicity (level >1.5) with polyuria indicates nephrogenic diabetes insipidus.
Treatment involves discontinuing lithium and volume expansion with IV normal saline to
enhance renal excretion. Sodium polystyrene sulfonate is used for hyperkalemia, not lithium.
Furosemide can worsen lithium retention. Increasing dose would exacerbate toxicity.

Q5.
A patient on digoxin develops nausea, blurred vision with yellow halos, and a serum
digoxin level of 3.2 ng/mL (therapeutic: 0.8-2.0). ECG shows atrial tachycardia with
variable AV block. Which intervention is contraindicated?


A. Administer digoxin immune Fab B. Correct hypokalemia with IV potassium
(Digibind) 40 mg IV chloride supplementation

C. Administer intravenous calcium gluconate D. Place patient on cardiac monitor and
for hyperkalemia if present prepare for transvenous pacing if
bradycardic
Correct: C - Administer intravenous calcium gluconate for hyperkalemia if present




Page 4

Document information

Uploaded on
August 5, 2026
Number of pages
73
Written in
2026/2027
Type
Exam (elaborations)
Contains
Questions & answers
$28.99

Wrong document? Swap it for free Within 14 days of purchase and before downloading, you can choose a different document. You can simply spend the amount again.
Written by students who passed
Immediately available after payment
Read online or as PDF

Seller avatar
Reputation scores are based on the amount of documents a seller has sold for a fee and the reviews they have received for those documents. There are three levels: Bronze, Silver and Gold. The better the reputation, the more your can rely on the quality of the sellers work.
PrepMart
4.9
(212)
Sold
120
Followers
1
Items
2098
Last sold
1 day ago



Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions